Join AIMBE for Quarterly Industry Council Call
CEO of MIODx Allen Northrup will be hosting his first quarterly call as AIMBE Industry Council Chair on Thursday, December 7 at 4 p.m. ET (1 p.m. PST) for up-to-date information on issues pertinent to MBE Industry Fellows. Guest speaker Dr. Roger Werne, Deputy Director of the Innovation and Partnerships Office, Lawrence Livermore National Laboratory will discuss “lessons learned” in the tech transfer space. He is responsible for licensing lab-developed intellectual property to the private sector. Werne has extensive experience in the commercialization of medical technologies. This call is open to ALL AIMBE Fellows interested in connecting with industry. Please see below for Dr. Werne’s slides. Dr. Roger Werne may be contacted directly at email@example.com.
AIMBE’s Industry Council: Your Partner in Fostering Innovation
The medical and biological engineering community has posted impressive achievements, greatly improving health and quality of life for millions around the world and providing the foundation for a cutting-edge industry that generates more than $200 billion per year in the U.S. alone.
That success has benefited from a collaboration among academia, business and government that is nurtured daily by AIMBE’s Industry Council. See benefits to membership in the AIMBE Industry Council here.
Members of the Industry Council – the companies and key corporate leaders of the bioengineering revolution – identify and act on common interests that will further advance medical and biological engineering and enhance public health and welfare.
AIMBE works on behalf of industry to maintain the pace of innovation and assure that progress in medical and biological engineering are integral to the national agenda. For lawmakers, regulators, the media and the public, AIMBE is an authoritative and respected source of information, perspectives and leadership on sometimes-mystifying technical and public policy issues. AIMBE and its Industry Council work in several areas of importance to industry’s policy concerns:
The AIMBE Center of Excellence for Accelerating Innovation works to develop a high-speed bridge between the laboratory and widespread application of bioengineering breakthroughs. The Center highlights the value of technology to policy makers, works to assure that NIH, FDA and other agencies are properly funded and collaborates with those agencies to streamline the innovation process.
The recently formed AIMBE/FDA Working Group works to remove innovation barriers within the FDA process and make AIMBE Fellows a source of ad hoc expertise for the FDA’s mission.
AIMBE hosted a forum in 2011 to develop best practices for Technology Transfer from Universities to private industry. The resulting white paper entitled “A Call to Action: Defining the Industry-Academic Relationships for Effective Technology Transfer” offers a roadmap for Universities and Industry collaborators to more efficiently speed translational research from basic research laboratories to patients.
AIMBE also is active on many other policy fronts critical to industry, including establishment of a permanent federal R&D tax credit.
Consumers can rely on AIMBE Fellows for credible information on issues of the merits and safety of medical breakthroughs. In an era of widespread public skepticism about new technologies, these respected researchers and academics offer independent, informed assurances that can make the difference between widespread acceptance and rejection of a product or procedure. The Industry Council works to assure that their voices are brought forward at appropriate times in public discussions.
As consultants to industry, AIMBE Fellows provide critical outside experience and expertise. They help companies find the missing linkages to new technological breakthroughs.
The academic centers represented within AIMBE are fertile ground for companies seeking the best engineering talent for their own laboratories. Industry Council membership enhances your company’s access to that talent pool, among both faculty members and the young minds they are training for careers that will mine the 21st century’s potential.
AIMBE and its Industry Council engage in collaborative and complementary relationships with the field’s foremost trade organizations. We are advocates on issues such as removing barriers to innovation and fostering the role of small business in bioengineering.
AIMBE works constantly to raise the profile and enhance the image of medical and biological engineering and its products. The AIMBE Hall of Fame – founded in 2005 to highlight a century of key innovations, and scheduled to receive new inductees in 2007 – demonstrates to the public and policy makers the importance of this field’s innovative drive in the past, present and future. And through its work to highlight the growing role and importance of women in the field, AIMBE motivates more bright and creative young people to join the drive forward.
Support for AIMBE’s Industry Council is vital to sustaining the pace of innovation.
Please join us as a partner building for the future.
M. Allen Northrup, Ph.D.
Chair 2017 – 2018
For outstanding contributions to bio-analytical and actuator-based micro-technologies, and for entrepreneurship in clinical diagnostics and homeland security.
Susan Drapeau, Ph.D.
Chair 2015 – 2016
Senior Director, Business Development & Strategy
For outstanding contributions to the innovation and development of clinical therapies to treat spinal, musculoskeletal and oral-maxillofacial diseases.
Walt Baxter, Ph.D.
Chair 2013 – 2014
Senior Principal Scientist
Medtronic Neuromodulation Therapy Delivery
For development of novel algorithms elucidating mechanics of implanted medical devices and major contributions to academia-industry collaboration and professional development.
David R. Jones
Chair 2011 – 2012
Former Director Quality, Regulatory and Compliance
Philips Home Healthcare Solutions
For having several invited peer reviewed papers for the IEEE and Quality and Realiability International.
Robert J. Miller, Ph.D.
Senior Vice President
For leadership in developing valuable medical products from natural sources in the fields of implantable devices, diagnostic tests and purification systems.
Joseph C. Salamone, Ph.D.
Chair 2006 – 2008
Chief Scientific Officer
For substantial scientific, technological, and commercial contributions to contact lenses and ophthalmic devices.